Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 2 Study of Bedaquiline in Japanese Patients with Pulmonary Multidrug-resistant Tuberculosis
jRCT2080223062Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bedaquiline in pulmonary tuberculosis (TB), sponsored by Janssen Pharmaceutical. Started Jan 2016; status: completed.
02
Drugs
bedaquiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on jRCT2080223062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223062.